Efficacy and safety of repeated use of lusutrombopag prior to radiofrequency ablation in patients with recurrent hepatocellular carcinoma and thrombocytopenia

AIMS: Thrombocytopenia is often associated with chronic liver disease. Lusutrombopag is a small molecule thrombopoietin receptor agonist designed to temporarily increase the platelet count in patients with chronic liver disease for whom elective invasive procedures are planned. In the present study,...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Hepatol Res
Glavni autori: Ishikawa, Toru, Okoshi, Marina, Tomiyoshi, Kei, Kojima, Yuichi, Horigome, Ryoko, Imai, Michitaka, Nozawa, Yujiro, Iwanaga, Akito, Sano, Tomoe, Honma, Terasu, Yoshida, Toshiaki
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2019
Teme:
Short Communication
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6849762/
https://ncbi.nlm.nih.gov/pubmed/30602063
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/hepr.13305
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items